Associated Costs Are a Barrier to HIV Preexposure Prophylaxis Access in the United States

HIV pre-exposure prophylaxis (PrEP), a biomedical HIV prevention intervention, reduces the risk of HIV acquisition by upwards of 90% for sexual encounters and 70% for injection drug use. If widely used, PrEP has the potential to help end the HIV epidemic in the United States.1 In 2015, the Centers f...

Ausführliche Beschreibung